Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapyEva Barragán, Pau Montesinos, Mireia Camós et al.|Haematologica|2011Cited by 65
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, Cristina Robledo et al.|British Journal of Cancer|2017Cited by 51
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1Jordi Esteve, Marı́a Rozman, José‐Tomás Navarro et al.|Annals of Hematology|2014Cited by 29
Clonal dynamics in pediatric B‐cell precursor acute lymphoblastic leukemia with very early relapseŽeljko Antić, Roland P. Kuiper, Cornelia Eckert et al.|Pediatric Blood & Cancer|2021Cited by 14
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on TreatmentNerea Vega‐García, Mireia Camós, Sara Pérez‐Jaume et al.|Frontiers in Pediatrics|2021Cited by 9